← Scoopfeeds — Intelligent news, curated.
Adaptive Biotech Q1 2026 slides: MRD revenue surges 53%, guidance raised
business

Adaptive Biotech Q1 2026 slides: MRD revenue surges 53%, guidance raised

Investing.com · May 5, 2026, 9:54 PM · Also reported by 1 other source

Adaptive Biotech Q1 2026 slides: MRD revenue surges 53%, guidance raised

Read full story on Investing.com → More top stories

Also covered by

CNBC Super Micro stock jumps 19% on guidance beat as revenue more than doubles

More in business

MarketWatch
Oil futures fall after Trump pauses U.S. effort to partially reopen Strait of Hormuz
Bloomberg Markets
Sydney Hedge Fund Regal Sees Inflows Jump for Inflation Hedges
CoinDesk
Michael Saylor's Strategy signals potential bitcoin sale to fund dividends obligations
Bloomberg Markets
Private Credit Fund Touts Quick Profit Buying Debt at 65 Cents
CNBC
Trump pauses U.S. bid to guide ships out of Strait of Hormuz, cites Iran deal progress
Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop